Editas Medicine, Inc. Common Stock vs. Halozyme Therapeutics, Inc.
EDIT
Editas Medicine, Inc. Common Stock
$2.68 +2.97%
VS HALOHalozyme Therapeutics, Inc.
$128.26 -0.28%
Editas Medicine, Inc. Common Stock and Halozyme Therapeutics, Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| EDIT | HALO | |
|---|---|---|
| Market Cap | $399.31 million | $14.60 billion |
HALO leads on 1 of 1 size & scale factors.
Risk & Sentiment
| EDIT | HALO | |
|---|---|---|
| Short Interest | 4.06% | 9.79% |
EDIT leads on 1 of 1 risk & sentiment factors.
Dig deeper: EDIT overview, EDIT financials, HALO overview, HALO financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.